Taken together, these findings demonstrate that DLEU1 is highly expressed in GC cells and drives malignant phenotypes by promoting cell proliferation, migration, and metabolic metabolism, while also enhancing DNA damage repair and conferring chemoresistance may thus represent a promising therapeutic strategy for overcoming DNA repair–mediated drug resistance in GC. The gene discussed is DLEU1; the disease is gastric cancer.